CYRAMZA, in combination with erlotinib, now approved for the treatment of people with untreated metastatic non-small cell lung cancer (NSCLC) with certain activating EGFR mutations, based on the positive global Phase 3 RELAY study   CYRAMZA regimen reduced the risk of disease progression or death

The first and only approved diagnostic agent to image tau neurofibrillary tangles in the brain INDIANAPOLIS , May 28, 2020 /PRNewswire/ -- TAUVID ™ , a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and

INDIANAPOLIS , May 26, 2020 /PRNewswire/ -- President Donald J. Trump and Seema Verma , Administrator for the Centers for Medicare & Medicaid Services , today announced details of the new Part D Senior Savings Model that will allow people in the Medicare Part D program to buy their monthly

- Ischemic heart disease, including myocardial infarction, is the leading cause of death in the U.S. - EMPACT-MI is the first trial in the SGLT2 inhibitor class to investigate the prevention of heart failure after acute myocardial infarction in adults with and without diabetes - The trial is part